Containing pandemic influenza at the source

Science

Volumn 309, Issue 5737, 2005, Pages 1083-1087

  Longini Jr , Ira M ^a   Nizam, Azhar ^a   Xu, Shufu ^a   Ungchusak, Kumnuan ^b   Hanshaoworakul, Wanna ^b   Cummings, Derek A T ^c   Halloran, M Elizabeth ^a  

^a EMORY UNIVERSITY   (United States)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SIMULATION; MATHEMATICAL MODELS; PROBABILITY; RANDOM PROCESSES; STRAIN;

ANTIVIRAL PROPHYLAXIS; PANDEMIC INFLUENZA; PREVACINATION; QUARANTINE;

DISEASES;

ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR;

INFLUENZA;

ARTICLE; DRUG EFFICACY; HUMAN; INFECTION CONTROL; INFLUENZA; PRIORITY JOURNAL; PROPHYLAXIS; SIMULATION; SOUTHEAST ASIA; STOCHASTIC MODEL; VACCINATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; ASIA, SOUTHEASTERN; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, STATISTICAL; QUARANTINE; STOCHASTIC PROCESSES; THAILAND; TIME FACTORS; VACCINATION;

AVES;

EID: 23644457957     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1115717     Document Type: Article

References (35)

1. R. J. Webby, R. G. Webster, Science 302, 1519 (2003).
2. M. Enserink, Science 306, 2016 (2004).
3. K. Stohr, N. Engl. J. Med. 352, 405 (2005).
4. A. S. Monto, N. Engl. J. Med. 352, 323 (2005).
5. N. M. Ferguson, C. Fraser, C. A. Donnelly, A. C. Ghani, R. M. Anderson, Science 304, 968 (2004).
6. K. Ungchusak et al., N. Engl. J. Med. 352, 333 (2005).
7. K. Stohr, M. Esveld, Science 306, 2195 (2004).
8. F. G. Hayden, Philos. Trans. R. Soc. London Ser. B 356, 1877 (2001).
9. R. G. Webster, Science 293, 1773 (2001).
10. G. Laver, E. Garman, Science 293, 1776 (2001).
11. A. S. Monto et al., JAMA 282, 31 (1999).
12. I. M. Longini, M. E. Halloran, A. Nizam, Y. Yang, Am. J. Epidemiol. 159, 623 (2004).
13. National Statistical Office, Population and Housing Census 2000 (available at www.nso.go.th, accessed 19 November 2004).
14. K. Faust, B. Entwisle, R. R. Rindfuss, S. J. Walsh, Y. Sawangdee, Soc. Networks 21, 311 (1999).
15. P. Guest, A. Chamraathrithirong, K. Arhavanitkul, N. Piriyathamwong, Asian Pacific Migrat. J. 3, 531 (1994).
16. A. Chamraathrithirong et al. National Migration Survey of Thailand (Institute for Population and Social Research, Mahidol Univeristy, Bangkok, Thailand, 1995).
17. L. R. Elveback et al., Am. J. Epidemiol. 103, 152 (1976).
18. E. D. Kilbourne, The Influenza Viruses and Influenza (Academic Press, New York, 1975).
19. L. A. Rvachev, I. M. Longini, Math. Biosci. 75, 3 (1985).
20. S. Cauchemez, F. Carrat, C. Viboud, A. J. Valleron, P. Y. Boëlle, Stat. Med. 23, 3469 (2004).
21. W. S. Jordan, Am. Rev. Res. Dis. 83, 29 (1961).
22. I. M. Longini, E. Ackerman, L. R. Elveback, Math. Biosci. 38, 141 (1978).
23. L. E. Davis, G. C. Caldwell, R. E. Lynch, R. E. Bailey, Am. J. Epidemiol. 92, 240 (1970).
24. R. G. Sharrar, Bull. World Health Org. 41, 361 (1969).
25. K. A. Fitzner, S. M. McGhee, A. J. Medley, K. F. Shortridge, Hong Kong Med. J. 5, 87 (1999).
26. F. G. Hayden, F. Y. Aoki, in Antimicrobial Therapy and Vaccines, V. Yu, T. Meigan, S. Barriere, Eds. (Williams and Wilkins, Baltimore, MD, 1999), pp. 1344-1365.
27. F. G. Hayden et al., N. Engl. J. Med. 343, 1282 (2000).
28. R. Welliver et al., JAMA 285, 748 (2001).
29. Y. Yang, I. M. Longini, M. E. Halloran, Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Croups (Technical Report 04-09, Department of Biostatistics, Emory University, Atlanta, GA, 22 July 2004) (available at www.sph.emory.edu/bios/ tech/).
30. M. E. Halloran, I. M. Longini, C. J. Struchiner, Epidemiol. Rev. Vaccines 21, 73 (1999).
31. A. N. Hill, I. M. Longini, Math. Biosci. 181, 85 (2003).
32. C. E. Mills, J. M. Robins, M. Lipsitch, Nature 432, 904 (2004).
33. R. Antia, R. R. Regoes, J. C. Koella, C. T. Bergstrom, Nature 426, 658 (2003).
34. M. E. Halloran, I. M. Longini, D. M. Cowart, A. Nizam, Vaccine 20, 3254 (2002).
35. This work was supported by National Institute of General Medical Sciences MIDAS grant U01-GM070749 and National Institute of Allergy and Infectious Diseases grant R01-AI32042. The authors thank F. Hayden, K. Stöhr, P. Glezen, A. Monto, S. Dowell, and B. Schwartz for their helpful comments.